- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05110859
QUALITATIVE SURVEY ABOUT NURSES FIRST WORK EXPERIENCE DURING COVID-19 PANDEMIC
PHENOMENOLOGICAL QUALITATIVE SURVEY ABOUT NURSES FIRST WORK EXPERIENCE DURING COVID-19 PANDEMIC AT PIACENZA HOSPITAL, ITALY
During covid-19 pandemic an huge reorganization of all PiacenzaHospital was done to manage the increasing requests for hosptitalization.
New nurses had to face first work experience in full pandemic Emergency. Altough even before the pandemic, being a newly graduated nurses was described as a stressful and isolating experience , we can't find studies in the literatureconcerning newly graduated and newly hired nurses during the pandemic pediod.
The study purpose is to describe and analyze, trough a phenomenological research, the experience of these nurses.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Maurizio Beretta, RN
- Phone Number: +39 0523 303856
- Email: m.beretta@ausl.pc.it
Study Locations
-
-
PC
-
Piacenza, PC, Italy, 29121
- Recruiting
- Piacenza Nursing School, University of Parma,
-
Contact:
- Maurizio Beretta, RN
- Phone Number: +39 0523 303852
- Email: m.beretta@ausl.pc.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults
- first work experience nurses after gratuation
- not opposed to partecipate to this study
Exclusion Criteria:
- refusing to partecipate
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
first work experience nurses
|
in-depth individual interviews to explore their perspectives on their first work experience during covid-19 pandemic
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
nurses satisfaction
Time Frame: 6 months
|
to detect emotional impact
|
6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Qual_NeoCOVID
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.